Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Deal Watch: Purdue Continues Move Away From Opioids With Alivio Deal

Mon, 01/28/2019 - 1:23pm

In its continuing efforts to diversify away from opioid pain drugs, Purdue partners on non-opioid program with Alivio. Rigel licenses...

      Related Stories 

Q4 Pharma Earnings Preview: Roche, Celgene, Novo Nordisk, Merck, Gilead

Mon, 01/28/2019 - 12:05pm

Roche will highlight newer drugs as cancer blockbusters feel biosimilar pressure, while Celgene will talk to investors about its pending...

      Related Stories 

Pipeline Watch: Phase III Results For Venofer, Lartruvo

Mon, 01/28/2019 - 2:08am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

UK's Midatech Makes Desperate Cash Call

Mon, 01/28/2019 - 2:05am

The Welsh biotech needs more money and fast to fund development of MTD201, which it believes offers a number of...

      Related Stories 

Real Estate Sale, Including Osaka HQ, To Raise $347m For Takeda

Sun, 01/27/2019 - 9:17pm

As part of efforts to raise cash to pay for its acquisition of Shire, Takeda will sell off selected real...

      Related Stories 

Potential Santen, Centaur India Eye Care Alliance Off

Sun, 01/27/2019 - 4:42pm

Indian firm Centaur confirms to Scrip that a planned alliance with Santen for the Indian market is not going ahead...

      Related Stories 

Q4 Earnings Preview: Pfizer, Amgen, Allergan, Biogen And Novartis

Fri, 01/25/2019 - 2:25pm

Pfizer's fourth-quarter call will be the first with new CEO Albert Bourla, while Amgen will provide reassurances after US Neulasta...

      Related Stories 

Finance Watch: Gossamer Works Around The Shutdown To Price Its $230m IPO

Fri, 01/25/2019 - 2:01pm

Gossamer took an infrequently used path to go public during a US government shutdown that's kept the SEC from processing...

      Related Stories 

AbbVie’s Downward Humira Guidance Worries Analysts

Fri, 01/25/2019 - 1:57pm

Decreasing Humira’s ex-US sales guidance for the second time in three months caught significant attention, as AbbVie now expects 30%...

      Related Stories 

Biosimilars Begin To 'Pay Off' For Biocon

Fri, 01/25/2019 - 7:17am

Biocon rang in a strong Q3, buoyed by the momentum in its biologics business. The firm appears undeterred by suggestions...

      Related Stories 

Fresh EU Okay For Rubraca Boosts Clovis

Fri, 01/25/2019 - 7:08am

Rumors that Clovis is going to be an M&A target soon are on the rise after a second thumbs-up in...

      Related Stories 

Juggling Gene Therapies: Sarepta's Focus Grows, With Many Balls In The Air

Thu, 01/24/2019 - 11:42am

CEO Doug Ingram talked with Scrip about Sarepta's plans to quickly build out a gene therapy pipeline, potentially launch another...

      Related Stories 

Shield Therapeutics Looking At US Options For Feraccru

Thu, 01/24/2019 - 7:41am

The UK biotech has revised its business strategy over the past year, and Shield's CEO believes the company's lead product...

      Related Stories 

Shield Therapeutics Looking At US Options For Ferracru

Thu, 01/24/2019 - 7:41am

The UK biotech has revised its business strategy over the past year, and Shield's CEO believes the company's lead product...

      Related Stories 

Pages